Breaking News Instant updates and real-time market news.

NOW

ServiceNow

$184.25

-0.63 (-0.34%)

16:12
07/25/18
07/25
16:12
07/25/18
16:12

ServiceNow sees Q3 subscription revenue $610M-$615M, up 36-37% from last year

  • 25

    Jul

NOW ServiceNow
$184.25

-0.63 (-0.34%)

06/15/18
SBSH
06/15/18
DOWNGRADE
Target $98
SBSH
Sell
Citi downgrades Splunk to Sell on 'plateauing' growth drivers
Citi analyst Walter Pritchard downgraded Splunk (SPLK) to Sell from Neutral with an unchanged price target of $98. The stock in premarket trading is down 4%, or $4.72, to $114.78. The analyst sees "growth drivers plateauing" and "some warning signs in numbers." Splunk is facing increasing competition, adoption challenges caused by a "persistently unconventional" pricing model and market share in security nearing levels where others have had challenge breaking through, Pritchard tells investors in a research note. Further, he believes the stock is "vulnerable" with a valuation in-line with high-growth software-as-a-service app players. The analyst recommends Salesforce (CRM) and Salesforce (NOW) or security peer Palo Alto Networks (PANW) over Splunk (SPLK).
07/02/18
SBSH
07/02/18
NO CHANGE
Target $200
SBSH
Buy
ServiceNow price target raised to $200 from $174 at Citi
Citi analyst Walter Pritchard raised his price target for ServiceNow to $200 after exploring avenues for the company to expand its total addressable market. The analyst sees "viable paths" for both organic investment and potential for up-tick in acquisitions. He believes ServiceNow has "ample medium-term market opportunity" to keep current growth sustained, mostly driven organically. The company's path to $4B in revenue is within sight with multi-product organic growth drivers, Pritchard tells investors in a research note titled "Plotting the Path Toward $10B in Revenue." The analyst keeps a Buy rating on the shares.
07/20/18
PIPR
07/20/18
NO CHANGE
Target $210
PIPR
Overweight
ServiceNow price target raised to $210 from $190 at Piper Jaffray
Piper Jaffray analyst Alex Zukin raised his price target for ServiceNow to $210 ahead of the company's Q2 results on July 25. The analyst, based on his channel checks, expects a "very strong" from ServiceNow. Checks suggest that ServiceNow's Q2 was ahead of internal expectations and "much better" than Q1, Zukin tells investors in a pre-earnings research note. He continues to believe the company is well positioned longer term and reiterates an Overweight rating on the shares.
07/20/18
OPCO
07/20/18
NO CHANGE
OPCO
Perform
ServiceNow shares look fully valued after 'strong' run-up YTD, says Oppenheimer
Oppenheimer analyst Brian Schwartz maintained a Perform rating on ServiceNow (NOW) ahead of the company's Q2 results on July 25, which he views as "solid." In a research note to investors, Schwartz says he thinks the shares look fully valued after a "strong" run-up year-to-date, adding that the tone from industry checks and June's visit to headquarters sounded "positive," but that the medium-term growth and margin framework remains uncertain. The analyst continues to recommend Salesforce (CRM) as the better play in the second half of the year.

TODAY'S FREE FLY STORIES

AMD

AMD

$33.59

-0.23 (-0.68%)

, INTC

Intel

$49.39

0.22 (0.45%)

04:59
07/18/19
07/18
04:59
07/18/19
04:59
Downgrade
AMD downgraded to Neutral from Buy at Mizuho »

Mizuho analyst Vijay…

AMD

AMD

$33.59

-0.23 (-0.68%)

INTC

Intel

$49.39

0.22 (0.45%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 30

    Jul

04:55
07/18/19
07/18
04:55
07/18/19
04:55
General news
Jobless Claims to be reported at 08:30 »

Week of 7/13 Jobless…

04:55
07/18/19
07/18
04:55
07/18/19
04:55
General news
Breaking General news story  »

6-Month Bill Announcement…

GMRE

Global Medical REIT

$10.51

-0.15 (-1.41%)

04:55
07/18/19
07/18
04:55
07/18/19
04:55
Conference/Events
Global Medical REIT management to meet with Oppenheimer »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 08

    Aug

TORC

ResTORbio

$10.42

0.19 (1.86%)

04:55
07/18/19
07/18
04:55
07/18/19
04:55
Conference/Events
ResTORbio management to meet with Wedbush »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

SUPV

Grupo Supervielle

$8.12

0.13 (1.63%)

04:55
07/18/19
07/18
04:55
07/18/19
04:55
Conference/Events
Grupo Supervielle management to meet with UBS »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 19

    Jul

04:55
07/18/19
07/18
04:55
07/18/19
04:55
General news
Philadelphia Fed Business Outlook Survey General Conditions Index to be reported at 08:30 »

July Philadelphia Fed…

04:55
07/18/19
07/18
04:55
07/18/19
04:55
General news
Leading Indicators to be reported at 10:00 »

June Leading Indicators…

CAMP

CalAmp

$10.82

-0.46 (-4.08%)

04:55
07/18/19
07/18
04:55
07/18/19
04:55
Conference/Events
CalAmp participates in a conference call with Northland »

Conference call with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 24

    Jul

  • 06

    Aug

04:55
07/18/19
07/18
04:55
07/18/19
04:55
General news
Breaking General news story  »

Week of 7/12 EIA Natural…

04:55
07/18/19
07/18
04:55
07/18/19
04:55
General news
Breaking General news story  »

4-Week Bill Auction to be…

CASY

Casey's General Stores

$160.43

0.08 (0.05%)

04:55
07/18/19
07/18
04:55
07/18/19
04:55
Conference/Events
Casey's General Stores management to meet with Northcoast »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 13

    Nov

OPNT

Opiant Pharmaceuticals

$13.24

-0.25 (-1.85%)

04:55
07/18/19
07/18
04:55
07/18/19
04:55
Conference/Events
Opiant Pharmaceuticals management to meet with Northland »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 19

    Jul

ACAD

Acadia

$25.56

-0.72 (-2.74%)

, BIIB

Biogen

$229.39

-2.17 (-0.94%)

04:55
07/18/19
07/18
04:55
07/18/19
04:55
Conference/Events
Alzheimer's Association to hold a conference »

Alzheimer's…

ACAD

Acadia

$25.56

-0.72 (-2.74%)

BIIB

Biogen

$229.39

-2.17 (-0.94%)

CRL

Charles River

$135.30

0.08 (0.06%)

DGX

Quest Diagnostics

$100.18

-1.28 (-1.26%)

ESALY

Eisai

$0.00

(0.00%)

PKI

PerkinElmer

$95.10

-0.24 (-0.25%)

RHHBY

Roche

$0.00

(0.00%)

MRK

Merck

$81.93

0.36 (0.44%)

NSTG

NanoString

$30.44

-0.06 (-0.20%)

PRAH

PRA Health

$98.05

-0.43 (-0.44%)

QTRX

Quanterix

$31.45

0.37 (1.19%)

SYNH

Syneos Health

$47.64

-1.07 (-2.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 23

    Jul

  • 25

    Jul

  • 25

    Jul

  • 29

    Jul

  • 30

    Jul

  • 31

    Jul

  • 31

    Jul

  • 31

    Jul

  • 01

    Aug

  • 06

    Aug

  • 06

    Aug

  • 08

    Aug

  • 18

    Aug

  • 19

    Aug

  • 26

    Aug

  • 02

    Sep

  • 09

    Sep

  • 13

    Sep

  • 16

    Sep

  • 20

    Sep

  • 02

    Oct

  • 04

    Nov

CGC

Canopy Growth

$36.57

1.015 (2.85%)

04:55
07/18/19
07/18
04:55
07/18/19
04:55
Conference/Events
Canopy Growth management to meet with Seaport Global »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

04:55
07/18/19
07/18
04:55
07/18/19
04:55
Conference/Events
The Brookings Institution to hold a conference on the US-China Trade War »

The Global Economy &…

04:55
07/18/19
07/18
04:55
07/18/19
04:55
Conference/Events
House Judiciary Committee to hold a hearing »

The Subcommittee on…

04:55
07/18/19
07/18
04:55
07/18/19
04:55
General news
Breaking General news story  »

8-Week Bill Auction to be…

04:55
07/18/19
07/18
04:55
07/18/19
04:55
General news
Breaking General news story  »

Week of 7/17 Fed Balance…

04:55
07/18/19
07/18
04:55
07/18/19
04:55
General news
Breaking General news story  »

New York Federal Reserve…

UBSFY

Ubisoft

$0.00

(0.00%)

, TTWO

Take-Two

$117.64

0.15 (0.13%)

04:55
07/18/19
07/18
04:55
07/18/19
04:55
Conference/Events
Wedbush digital media analyst to hold an analyst/industry conference call »

Digital Media Analyst…

UBSFY

Ubisoft

$0.00

(0.00%)

TTWO

Take-Two

$117.64

0.15 (0.13%)

NTDOY

Nintendo

$0.00

(0.00%)

GME

GameStop

$4.39

-0.245 (-5.29%)

EA

Electronic Arts

$89.72

0.15 (0.17%)

ATVI

Activision Blizzard

$46.69

-0.29 (-0.62%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

  • 30

    Jul

  • 05

    Aug

  • 08

    Aug

  • 08

    Aug

  • 05

    Sep

  • 13

    Nov

GLMD

Galmed

$6.30

-0.2 (-3.08%)

, CBAY

CymaBay

$6.39

-0.15 (-2.29%)

04:55
07/18/19
07/18
04:55
07/18/19
04:55
Conference/Events
Cantor Fitzgerald biotech analysts to hold a KOL luncheon meeting »

Biotech Analysts Young…

GLMD

Galmed

$6.30

-0.2 (-3.08%)

CBAY

CymaBay

$6.39

-0.15 (-2.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

04:55
07/18/19
07/18
04:55
07/18/19
04:55
Conference/Events
William Blair enterprise & cloud infrastructure analyst to hold a group luncheon »

Enterprise & Cloud…

DOVA

Dova Pharmaceuticals

$16.01

-0.06 (-0.37%)

04:55
07/18/19
07/18
04:55
07/18/19
04:55
Conference/Events
Dova Pharmaceuticals management to meet with Jefferies »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

04:55
07/18/19
07/18
04:55
07/18/19
04:55
Conference/Events
Piper Jaffray to hold a conference »

BioInsights KOL Series…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.